MDWD
NASDAQ HealthcareMediWound Ltd. - Ordinary Shares
Biotechnology
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
�� 市场数据
| 价格 | $13.86 |
|---|---|
| 成交量 | 154,406 |
| 市值 | 178.94M |
| 贝塔系数 | 0.090 |
| RSI（14日） | 63.5 |
| 200日均线 | $15.25 |
| 50日均线 | $13.05 |
| 52周最高 | $19.70 |
| 52周最低 | $11.80 |
| Forward P/E | -6.05 |
| Price / Book | 5.02 |
🎯 投资策略评分
MDWD 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🎈 Over-Hyped (65/100) — 此策略 超买股票（潜在做空标的）.
评分最低的策略： 🐋 Institutional Whale (2/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 MDWD in your text
粘贴任何文章、记录或帖子 — 工具将提取 MDWD 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-10-29.